20:50:14 EDT Tue 11 Aug 2020
Enter Symbol
or Name
USA
CA



Arev Nanotec Brands Inc
Symbol AREV
Shares Issued 9,457,808
Close 2020-04-09 C$ 0.085
Recent Sedar Documents

Arev Nanotec closes IP asset acquisition from Chiron

2020-04-09 17:14 ET - News Release

Mr. Mike Withrow reports

AREV ASSET PURCHASE COMPLETED

Arev Nanotec Brands Inc. has completed an asset purchase and sale agreement dated April 4, 2020, with Chiron Capital Inc., a wholly owned B.C. corporation of Mike Withrow. The company has acquired certain intellectual property, engineering know-how, business models and trade secrets related to extraction technology of the equipment that Arev had previously purchased from Alternative Extracts Inc.

The rights, title and interest to the intellectual property were purchased for $200,000, free and clear of any encumbrances. The company believes that owning this key technology and methods to the equipment it already owns advances the company forward in the current market. Now Arev has ownership of advanced IP and technology and does not have to rely on a vendor to make custom changes to the equipment when innovating and developing its new nano particulate extraction products. Having this IP enables the company to develop proprietary-process high-value pharmaceutical-grade compounds such as Fondoside -A, piperine and curcumin.

Arev has developed proprietary methods to extract and produce nano particulates from raw materials like astaxanthin, sea cucumber, hops, Frankincense, myrrh, ginseng, kampot pepper, turmeric and functional mushrooms. On a recent trip to Vietnam, Mr. Withrow sourced a fabrication company that is manufacturing custom centrifuges, screw presses and grinders for Arev. These pieces are all part of the methodology and systems that Arev can now produce from the IP. For example, Frankinsence contains a little known compound called viridiflorol, which has shown moderate antibacterial activity against Mycobacterium tuberculosis, the causative agent of tuberculosis, in an in vitro assay. It is also an effective anti-inflammatory. This is just one example of the many high-value compounds the company can now produce.

The company recently changed its name to better reflect the innovation with nanotechnology it is working on, with a focus on extracting and fractioning compounds used in the fight against inflammation and viral infections.

Mr. Withrow stated, "This acquisition gives Arev the ability to keep trade secrets proprietary and file patents on our technology and methods in our own name." He went on to say, "We now have a solid competitive advantage and we are diversified in the biomass we can process on any scale."

About Arev Nanotec Brands Inc.

Arev produces and sells functional ingredients produced via its proprietary extraction systems. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical and sport nutrition markets. Arev's model is to toll process extraction of targeted essential and functional oils and license its formulations to licensed producers in Canada. The company uses toll processors in foreign countries to encapsulate and package formulations that can be sold in traditional distribution channels and on-line.

We seek Safe Harbor.

© 2020 Canjex Publishing Ltd. All rights reserved.